David Allen

David Allen, PhD has extensive work experience in the field of biotherapeutics and pharmaceutical development. David most recently worked as a Sr. Scientist in Nonclinical Development at Latigo Biotherapeutics, Inc. starting in June 2023. Prior to that, they served as a Sr. Manager in Nonclinical Development at atai Life Sciences from April 2022 to March 2023. Before that, they worked as a Project Management and Clinical Pharmacology Specialist at Nuventra Pharma Sciences from April 2021 to April 2022. David also worked as a Post Doctoral Fellow at the Children's Hospital of Philadelphia from July 2018 to April 2021. David began their career as a Postdoctoral Fellow at the University of Minnesota, where they also served as a lab manager and supervised five junior lab members. David completed their PhD at the University of Minnesota in December 2017.

David Allen, PhD pursued their higher education at the University of Minnesota from 2012 to 2017. During this period, they earned their Doctor of Philosophy (PhD) degree in Experimental and Clinical Pharmacology.